Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
48.46
+0.20 (+0.41%)
Official Closing Price
Updated: 7:00 PM EST, Nov 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
13,520,510
Open
47.91
Bid (Size)
48.47 (100)
Ask (Size)
48.56 (200)
Prev. Close
48.26
Today's Range
47.72 - 49.19
52wk Range
45.05 - 112.52
Shares Outstanding
N/A
Dividend Yield
4.54%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Price Over Earnings Overview: Novo Nordisk
↗
November 17, 2025
Via
Benzinga
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight
↗
November 17, 2025
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.
Via
Benzinga
Topics
ETFs
Performance
YTD
-44.6%
-44.6%
1 Month
-13.1%
-13.1%
3 Month
-9.8%
-9.8%
6 Month
-27.7%
-27.7%
1 Year
-51.4%
-51.4%
More News
Read More
Novo Nordisk Leans Into Affordability Amid Rising Competition
↗
November 17, 2025
Via
Benzinga
Novo Nordisk's New Chair Aims To Reinforce Board As Foundation Tightens Control
↗
November 17, 2025
Via
Benzinga
Omeros (OMER) Q3 2025 Earnings Call Transcript
↗
November 17, 2025
Via
The Motley Fool
Topics
Derivatives
Earnings
How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration
↗
November 17, 2025
Via
Investor's Business Daily
Topics
Government
Novo Nordisk Offers WeGovy, Ozempic For $199 A Month As It Takes On Eli Lilly’s Zepbound
↗
November 17, 2025
Via
Stocktwits
Topics
Artificial Intelligence
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
↗
November 17, 2025
Via
The Motley Fool
Topics
ETFs
Government
World Trade
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks?
↗
November 16, 2025
Via
The Motley Fool
Topics
Government
Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market
↗
November 14, 2025
Via
Benzinga
Novo Nordisk Brings Back Former CEO To Lead Board
↗
November 14, 2025
Via
Stocktwits
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Did Scholar Rock Soar 26% Today?
↗
November 14, 2025
Via
Stocktwits
Topics
Earnings
Ozempic Maker Novo Nordisk Faces Board Shakeup
↗
November 14, 2025
Via
Benzinga
Is It Too Late to Buy Novo Nordisk After the Drop?
↗
November 14, 2025
Via
The Motley Fool
Why Is Everyone Talking About Novo Nordisk Stock?
↗
November 14, 2025
Via
The Motley Fool
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO
↗
November 14, 2025
Via
Stocktwits
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
↗
November 13, 2025
Via
Stocktwits
Korro Bio Early Trial Results Fall Short; Stock Hits New Low
↗
November 13, 2025
Via
Benzinga
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report
↗
November 13, 2025
Via
Stocktwits
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
↗
November 13, 2025
Via
Benzinga
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs
↗
November 13, 2025
Via
Stocktwits
1 Incredible Reason to Buy LLY's Stock in November
↗
November 13, 2025
Via
The Motley Fool
Topics
Government
World Trade
Eli Lilly Soars: A Pharmaceutical Giant's Breakout Fueled by Blockbuster Drugs and Strategic Vision
November 12, 2025
Via
MarketMinute
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker
↗
November 12, 2025
Via
Benzinga
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.46
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 11/17/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.